Magen David Adom (MDA) paramedics on Israeli Intensive Care ambulances and helicopters will use ultrasound probes to monitor patients’ hearts and locate IV points in hard-to-detect veins. If an ultrasound detects a heartbeat but no pulse, fluids should be used … Continue reading →

Tel Aviv University scientists have developed a new learning method for people with autism that may significantly improve capabilities in terms of visual perception. It uses “memory flashes” to reinforce the duration and repetition of new skills. https://www.aftau.org/news_item/new-learning-method-from-tau-could-help-people-with-autism-improve-visual-perception-capabilities/ https://www.cell.com/current-biology/fulltext/S0960-9822(22)00903-4

Israel’s Identifai Genetics is developing a noninvasive prenatal test for the early detection of severe genetic disorders. A simple blood test of the mother in her first trimester can detect every single-point mutation, insertion-deletion, and structural variation in the entire … Continue reading →

Intel Corporation is working with the ARC Innovation Center at Israel’s Sheba Medical Center to develop an AI-enhanced app to help physicians diagnose Crohn’s disease at an early stage. 12,000 images taken by a “capsule pill” can be analyzed in … Continue reading →

The medical condition fibromyalgia is hard to diagnose. Now, researchers at Haifa’s Rambam Health Care Campus and Canada’s McGill University can identify it in blood tests using an algorithm that analyzes the bile acids produced by gut bacteria. The scientists … Continue reading →

Israeli pharmacist Eliana Steinberg realized her medicines were not curing cancer patients and went back to university to get a doctorate. She then developed a transparent chip, which takes a sample of the tumor to test numerous treatments to discover … Continue reading →

Israel’s Nanovation-GS (see here previously) is now undergoing clinical trials in Israel and the EU of its SenseGuard first-of-its-kind nano-sensor for monitoring and managing chronic respiratory conditions. It is also working to obtain CE certification, with FDA approval to be … Continue reading →

Israeli-UK biotech Eleven Therapeutics is developing RNAi therapy that attacks the genetic structure of respiratory viruses such as SARS-COV-2. Eleven has just received a $9 million grant from the Gates Foundation. https://www.calcalistech.com/ctechnews/article/h1ju600ltc https://www.eleventx.com/

A team of Israeli immunologists, epidemiologists and other researchers have successfully used the levels of antibody markers to predict the risk of Covid-19 infection. IGG antibodies for 608 healthy adults were monitored over 90 days. The 239 subsequent infections were … Continue reading →